naloxonazine has been researched along with ng-nitroarginine methyl ester in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutkowska, J; Jankowski, M; Mukaddam-Daher, S; Schiller, PW | 1 |
1 other study(ies) available for naloxonazine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
The cardiovascular and renal effects of the potent and highly selective mu opioid agonist [Dmt1]DALDA.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Enzyme Inhibitors; Female; Gene Expression; Heart Rate; Hemodynamics; Homeostasis; Kidney; Myocardium; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Vasopressins | 2004 |